Response to ‘comparison of “sequential” versus “standard” chemotherapy as re-induction treatment, with or without cyclosporine, in refractory/relapsed acute myeloid leukaemia (aml): results of the uk medical research council aml-r trial’
2003 ◽
Vol 122
(1)
◽
pp. 164-165
◽
2001 ◽
Vol 113
(3)
◽
pp. 713-726
◽
1999 ◽
Vol 106
(2)
◽
pp. 436-444
◽
2011 ◽
Vol 155
(3)
◽
pp. 366-376
◽
2015 ◽
Vol 170
(4)
◽
pp. 590-593
◽
2006 ◽
Vol 132
(5)
◽
pp. 576-583
◽
Keyword(s):